Nasdaq-Listed WINT Makes Surprising Move with BNB InvestmentMajor Funding Secured Windtree Therapeutics (WINT), a Nasdaq-listed biotech company, has announced the signing of a 500 million equity line of credit (ELOC) along with an additional20 million stock purchase agreement. This brings the total available fundin Yug Ocean @YugOcean